- $25.77m
- $22.76m
- $5.91m
- 72
- 84
- 49
- 78
Annual income statement for Bexil, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 7.53 | 0.667 | 8.7 | -0.386 | 5.91 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 2.05 | 0.862 | 1.99 | 1.76 | 2.01 |
| Operating Profit | 5.49 | -0.195 | 6.71 | -2.14 | 3.9 |
| Net Income Before Taxes | 5.49 | -0.195 | 6.71 | -2.14 | 3.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 4.51 | 0.965 | 6.49 | -1.76 | 3.15 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 4.51 | 0.968 | 6.49 | -1.76 | 3.15 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 4.51 | 0.968 | 6.49 | -1.76 | 3.15 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 5.13 | 0.426 | 7.99 | -2.42 | 4.41 |